483
Granules Pharmaceuticals Inc.FDA 483 - Granules Pharmaceuticals Inc. - August 21, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Granules Pharmaceuticals Inc. in Chantilly, VA, was issued a Form 483 following an inspection from August 7-21, 2019. The inspection revealed that incoming components were not stored under quarantine until released, and the firm failed to follow its written procedures for the storage of components. These issues indicate deficiencies in material control and adherence to established quality procedures.
Open in Dashboard
ID · 56ccf589-fc0f-403a-81ea-fef283c58c0d